The Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid

Figure 3

Interindividual variability in the absolute change in polyunsaturated fatty acids (PUFAs) content of plasma and red blood cell (RBC) membrane from baseline to week 8 in healthy volunteers (HV) and inflammatory bowel disease (IBD) patients. LA: linoleic acid; AA: arachidonic acid; EPA: eicosapentaenoic acid; DPA: docosapentaenoic acid; DHA: docosahexaenoic acid.

(a)

(b)

(c)

(d)